Related Experiment Videos

Type 2 diabetes: a well-characterised but suboptimally controlled disease. Can we bridge the divide?

L Monnier1, C Colette, D R Owens

  • 1Laboratory of Human Nutrition, University Institute of Clinical Research, 34093 Montpellier cedex 5, France. l-monnier@chu-montpellier.fr

Diabetes & Metabolism
|May 31, 2008
PubMed

Insights

Type 2 diabetes involves three core mechanisms: impaired beta-cell function, reduced glucose uptake, and liver overproduction. Effective treatment requires identifying patient-specific pathophysiological stages for optimal glycemic control.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Diabetes Pathophysiology

Background:

  • Type 2 diabetes (T2D) is characterized by three primary pathophysiological defects: beta-cell dysfunction, peripheral insulin resistance, and hepatic glucose overproduction (De Fronzo's triumvirate).
  • These defects exhibit circadian variations and progressively worsen over time, complicating disease management.
  • Current therapeutic strategies often fall short due to challenges in aligning treatments with individual patient progression and physiological variability.

Purpose of the Study:

  • To emphasize the critical need for accurate pathophysiological staging in type 2 diabetes management.
  • To highlight the importance of tailoring therapeutic strategies based on individual disease progression and insulin secretory capacity.
  • To address the gap between understanding T2D pathophysiology and achieving optimal glycemic control in clinical practice.

Main Methods:

  • Assessment of pathophysiological stages using HbA1c levels and glycemic profiles.
  • Utilizing both self-monitoring of blood glucose (SMBG) and continuous glucose monitoring (CGM) for glycemic profiling.
  • Analyzing the impact of stochastic factors on therapeutic efficacy.

Main Results:

  • Identifying distinct pathophysiological stages is essential for successful therapeutic interventions in T2D.
  • Glycemic control remains suboptimal due to difficulties in managing variable physiological factors.
  • Challenges exist in delivering consistent therapeutic doses amidst fluctuations in carbohydrate absorption and drug pharmacokinetics/pharmacodynamics.

Conclusions:

  • Personalized therapeutic approaches are crucial for effective type 2 diabetes management.
  • Bridging the gap between pathophysiological understanding and clinical practice requires addressing variability in patient responses and treatment delivery.
  • Further research is needed to optimize treatment strategies for stochastic phenomena in T2D.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...